チロシンキナーゼ阻害剤の世界市場2024~2028

◆英語タイトル:Global Tyrosine Kinase Inhibitors Market 2024-2028

Technavioが発行した調査報告書(IRTNTR74141-24)◆商品コード:IRTNTR74141-24
◆発行会社(リサーチ会社):Technavio
◆発行日:2024年1月
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア太平洋、その他地域
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

チロシンキナーゼ阻害剤の世界市場 2024-2028
チロシンキナーゼ阻害剤市場は、2023-2028年に242億2000万米ドルで成長し、予測期間中のCAGRは8.42%で加速すると予測されます。当レポートでは、チロシンキナーゼ阻害剤市場について、市場規模や予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析など、包括的な分析を掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、チロシンキナーゼ阻害剤の高い標的親和性と特異性、患者支援プログラムの利用可能性の上昇、世界的な癌の有病率の増加が牽引しています。

Technavioのチロシンキナーゼ阻害剤市場は以下のようにセグメント化されている:

販売チャネル別
• オフライン
• オンライン

製品別
• RTKIs
• nRTKI

地域別
• 北米
• 欧州
• アジア
• その他の地域(ROW)

本調査では、今後数年間のチロシンキナーゼ阻害剤市場の成長を促進する主な要因の一つとして、市場ベンダー間の戦略的提携を挙げています。また、チロシンキナーゼ阻害剤治療における研究領域の拡大や、バイオシミラーの上市の増加は、市場の大きな需要につながると考えられます。

本レポートでは、チロシンキナーゼ阻害剤市場について、以下の分野を取り上げている:
• チロシンキナーゼ阻害剤市場のサイジング
• チロシンキナーゼ阻害薬市場予測
• チロシンキナーゼ阻害剤市場の産業分析

本レポートでは、AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Danaher Corp., Deciphera Pharmaceuticals Inc., Eisai Co. Ltd., Eli Lilly and Co., Exelixis Inc., F. Hoffmann La Roche Ltd., Johnson and Johnson, Merck KGaA, Novartis AG, Pfizer Inc., Puma Biotechnology Inc., Rigel Pharmaceuticals Inc., Takeda Pharmaceutical Co. Ltd., and Tokyo Chemical Industry Co. Ltd. を含むいくつかの主要なチロシンキナーゼ阻害剤市場ベンダーの詳細な分析を提供します。また、チロシンキナーゼ阻害剤市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場および企業状況プが含まれています。

当出版社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場状況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 チロシンキナーゼ阻害剤の世界市場:流通チャネル別
7 チロシンキナーゼ阻害剤の世界市場:製品別
8 顧客状況
9 地域別状況
10 推進要因・課題・動向
11 企業状況
12 企業分析
13 付録

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global tyrosine kinase inhibitors market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global tyrosine kinase inhibitors market 2018 – 2022 ($ billion)
o 4.2 Distribution channel Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Distribution channel Segment 2018 – 2022 ($ billion)
o 4.3 Product Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Product Segment 2018 – 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Distribution Channel – Market share 2023-2028 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Offline – Market size and forecast 2023-2028
o Exhibit 34: Chart on Offline – Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Offline – Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Offline – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Offline – Year-over-year growth 2023-2028 (%)
o 6.4 Online – Market size and forecast 2023-2028
o Exhibit 38: Chart on Online – Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Online – Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Online – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Online – Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Distribution Channel
o Exhibit 42: Market opportunity by Distribution Channel ($ billion)
o Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ billion)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 44: Chart on Product – Market share 2023-2028 (%)
o Exhibit 45: Data Table on Product – Market share 2023-2028 (%)
o 7.2 Comparison by Product
o Exhibit 46: Chart on Comparison by Product
o Exhibit 47: Data Table on Comparison by Product
o 7.3 RTKIs – Market size and forecast 2023-2028
o Exhibit 48: Chart on RTKIs – Market size and forecast 2023-2028 ($ billion)
o Exhibit 49: Data Table on RTKIs – Market size and forecast 2023-2028 ($ billion)
o Exhibit 50: Chart on RTKIs – Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on RTKIs – Year-over-year growth 2023-2028 (%)
o 7.4 nRTKIs – Market size and forecast 2023-2028
o Exhibit 52: Chart on nRTKIs – Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on nRTKIs – Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on nRTKIs – Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on nRTKIs – Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Product
o Exhibit 56: Market opportunity by Product ($ billion)
o Exhibit 57: Data Table on Market opportunity by Product ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 63: Chart on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 64: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 66: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 67: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 68: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 69: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 71: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 72: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 75: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 79: Chart on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 Germany – Market size and forecast 2023-2028
o Exhibit 83: Chart on Germany – Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on Germany – Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.9 UK – Market size and forecast 2023-2028
o Exhibit 87: Chart on UK – Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on UK – Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.10 China – Market size and forecast 2023-2028
o Exhibit 91: Chart on China – Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on China – Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.11 Canada – Market size and forecast 2023-2028
o Exhibit 95: Chart on Canada – Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on Canada – Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on Canada – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Canada – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 107: AbbVie Inc. – Overview
o Exhibit 108: AbbVie Inc. – Product / Service
o Exhibit 109: AbbVie Inc. – Key news
o Exhibit 110: AbbVie Inc. – Key offerings
o 12.4 Amgen Inc.
o Exhibit 111: Amgen Inc. – Overview
o Exhibit 112: Amgen Inc. – Product / Service
o Exhibit 113: Amgen Inc. – Key offerings
o 12.5 AstraZeneca Plc
o Exhibit 114: AstraZeneca Plc – Overview
o Exhibit 115: AstraZeneca Plc – Product / Service
o Exhibit 116: AstraZeneca Plc – Key news
o Exhibit 117: AstraZeneca Plc – Key offerings
o 12.6 Bayer AG
o Exhibit 118: Bayer AG – Overview
o Exhibit 119: Bayer AG – Business segments
o Exhibit 120: Bayer AG – Key news
o Exhibit 121: Bayer AG – Key offerings
o Exhibit 122: Bayer AG – Segment focus
o 12.7 Boehringer Ingelheim International GmbH
o Exhibit 123: Boehringer Ingelheim International GmbH – Overview
o Exhibit 124: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 125: Boehringer Ingelheim International GmbH – Key news
o Exhibit 126: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 127: Boehringer Ingelheim International GmbH – Segment focus
o 12.8 Bristol Myers Squibb Co.
o Exhibit 128: Bristol Myers Squibb Co. – Overview
o Exhibit 129: Bristol Myers Squibb Co. – Product / Service
o Exhibit 130: Bristol Myers Squibb Co. – Key news
o Exhibit 131: Bristol Myers Squibb Co. – Key offerings
o 12.9 Danaher Corp.
o Exhibit 132: Danaher Corp. – Overview
o Exhibit 133: Danaher Corp. – Business segments
o Exhibit 134: Danaher Corp. – Key news
o Exhibit 135: Danaher Corp. – Key offerings
o Exhibit 136: Danaher Corp. – Segment focus
o 12.10 Eisai Co. Ltd.
o Exhibit 137: Eisai Co. Ltd. – Overview
o Exhibit 138: Eisai Co. Ltd. – Business segments
o Exhibit 139: Eisai Co. Ltd. – Key offerings
o Exhibit 140: Eisai Co. Ltd. – Segment focus
o 12.11 Eli Lilly and Co.
o Exhibit 141: Eli Lilly and Co. – Overview
o Exhibit 142: Eli Lilly and Co. – Product / Service
o Exhibit 143: Eli Lilly and Co. – Key news
o Exhibit 144: Eli Lilly and Co. – Key offerings
o 12.12 Exelixis Inc.
o Exhibit 145: Exelixis Inc. – Overview
o Exhibit 146: Exelixis Inc. – Product / Service
o Exhibit 147: Exelixis Inc. – Key offerings
o 12.13 F. Hoffmann La Roche Ltd.
o Exhibit 148: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 149: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 150: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 151: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 152: F. Hoffmann La Roche Ltd. – Segment focus
o 12.14 Johnson and Johnson
o Exhibit 153: Johnson and Johnson – Overview
o Exhibit 154: Johnson and Johnson – Business segments
o Exhibit 155: Johnson and Johnson – Key news
o Exhibit 156: Johnson and Johnson – Key offerings
o Exhibit 157: Johnson and Johnson – Segment focus
o 12.15 Novartis AG
o Exhibit 158: Novartis AG – Overview
o Exhibit 159: Novartis AG – Business segments
o Exhibit 160: Novartis AG – Key offerings
o Exhibit 161: Novartis AG – Segment focus
o 12.16 Pfizer Inc.
o Exhibit 162: Pfizer Inc. – Overview
o Exhibit 163: Pfizer Inc. – Product / Service
o Exhibit 164: Pfizer Inc. – Key news
o Exhibit 165: Pfizer Inc. – Key offerings
o 12.17 Takeda Pharmaceutical Co. Ltd.
o Exhibit 166: Takeda Pharmaceutical Co. Ltd. – Overview
o Exhibit 167: Takeda Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 168: Takeda Pharmaceutical Co. Ltd. – Key news
o Exhibit 169: Takeda Pharmaceutical Co. Ltd. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 170: Inclusions checklist
o Exhibit 171: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 172: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 173: Research methodology
o Exhibit 174: Validation techniques employed for market sizing
o Exhibit 175: Information sources
o 13.5 List of abbreviations
o Exhibit 176: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global tyrosine kinase inhibitors market 2018 – 2022 ($ billion)
Exhibits19: Historic Market Size – Distribution channel Segment 2018 – 2022 ($ billion)
Exhibits20: Historic Market Size – Product Segment 2018 – 2022 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Distribution Channel – Market share 2023-2028 (%)
Exhibits31: Data Table on Distribution Channel – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Offline – Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Offline – Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Offline – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Offline – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Online – Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Online – Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Online – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Online – Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Distribution Channel ($ billion)
Exhibits43: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits44: Chart on Product – Market share 2023-2028 (%)
Exhibits45: Data Table on Product – Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Product
Exhibits47: Data Table on Comparison by Product
Exhibits48: Chart on RTKIs – Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on RTKIs – Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on RTKIs – Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on RTKIs – Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on nRTKIs – Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on nRTKIs – Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on nRTKIs – Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on nRTKIs – Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Product ($ billion)
Exhibits57: Data Table on Market opportunity by Product ($ billion)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits64: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits65: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on US – Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on US – Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Germany – Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Germany – Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on UK – Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on UK – Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on China – Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on China – Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Canada – Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Canada – Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Canada – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Canada – Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ billion)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: AbbVie Inc. – Overview
Exhibits108: AbbVie Inc. – Product / Service
Exhibits109: AbbVie Inc. – Key news
Exhibits110: AbbVie Inc. – Key offerings
Exhibits111: Amgen Inc. – Overview
Exhibits112: Amgen Inc. – Product / Service
Exhibits113: Amgen Inc. – Key offerings
Exhibits114: AstraZeneca Plc – Overview
Exhibits115: AstraZeneca Plc – Product / Service
Exhibits116: AstraZeneca Plc – Key news
Exhibits117: AstraZeneca Plc – Key offerings
Exhibits118: Bayer AG – Overview
Exhibits119: Bayer AG – Business segments
Exhibits120: Bayer AG – Key news
Exhibits121: Bayer AG – Key offerings
Exhibits122: Bayer AG – Segment focus
Exhibits123: Boehringer Ingelheim International GmbH – Overview
Exhibits124: Boehringer Ingelheim International GmbH – Business segments
Exhibits125: Boehringer Ingelheim International GmbH – Key news
Exhibits126: Boehringer Ingelheim International GmbH – Key offerings
Exhibits127: Boehringer Ingelheim International GmbH – Segment focus
Exhibits128: Bristol Myers Squibb Co. – Overview
Exhibits129: Bristol Myers Squibb Co. – Product / Service
Exhibits130: Bristol Myers Squibb Co. – Key news
Exhibits131: Bristol Myers Squibb Co. – Key offerings
Exhibits132: Danaher Corp. – Overview
Exhibits133: Danaher Corp. – Business segments
Exhibits134: Danaher Corp. – Key news
Exhibits135: Danaher Corp. – Key offerings
Exhibits136: Danaher Corp. – Segment focus
Exhibits137: Eisai Co. Ltd. – Overview
Exhibits138: Eisai Co. Ltd. – Business segments
Exhibits139: Eisai Co. Ltd. – Key offerings
Exhibits140: Eisai Co. Ltd. – Segment focus
Exhibits141: Eli Lilly and Co. – Overview
Exhibits142: Eli Lilly and Co. – Product / Service
Exhibits143: Eli Lilly and Co. – Key news
Exhibits144: Eli Lilly and Co. – Key offerings
Exhibits145: Exelixis Inc. – Overview
Exhibits146: Exelixis Inc. – Product / Service
Exhibits147: Exelixis Inc. – Key offerings
Exhibits148: F. Hoffmann La Roche Ltd. – Overview
Exhibits149: F. Hoffmann La Roche Ltd. – Business segments
Exhibits150: F. Hoffmann La Roche Ltd. – Key news
Exhibits151: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits152: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits153: Johnson and Johnson – Overview
Exhibits154: Johnson and Johnson – Business segments
Exhibits155: Johnson and Johnson – Key news
Exhibits156: Johnson and Johnson – Key offerings
Exhibits157: Johnson and Johnson – Segment focus
Exhibits158: Novartis AG – Overview
Exhibits159: Novartis AG – Business segments
Exhibits160: Novartis AG – Key offerings
Exhibits161: Novartis AG – Segment focus
Exhibits162: Pfizer Inc. – Overview
Exhibits163: Pfizer Inc. – Product / Service
Exhibits164: Pfizer Inc. – Key news
Exhibits165: Pfizer Inc. – Key offerings
Exhibits166: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibits167: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibits168: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibits169: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibits170: Inclusions checklist
Exhibits171: Exclusions checklist
Exhibits172: Currency conversion rates for US$
Exhibits173: Research methodology
Exhibits174: Validation techniques employed for market sizing
Exhibits175: Information sources
Exhibits176: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ チロシンキナーゼ阻害剤の世界市場2024~2028(Global Tyrosine Kinase Inhibitors Market 2024-2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆